Unknown

Dataset Information

0

Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.


ABSTRACT: UNLABELLED:The sublingual route has been proposed as a needle-free option to induce systemic and mucosal immune protection against viral infections. In a translational study of systemic and mucosal humoral immune responses to sublingual or systemically administered viral antigens, eighteen healthy female volunteers aged 19-31 years received three immunizations with a quadravalent Human Papilloma Virus vaccine at 0, 4 and 16 weeks as sublingual drops (SL, n = 12) or intramuscular injection (IM, n = 6). IM antigen delivery induced or boosted HPV-specific serum IgG and pseudovirus-neutralizing antibodies, HPV-specific cervical and vaginal IgG, and elicited circulating IgG and IgA antibody secreting cells. SL antigens induced ~38-fold lower serum and ~2-fold lower cervical/vaginal IgG than IM delivery, and induced or boosted serum virus neutralizing antibody in only 3/12 subjects. Neither route reproducibly induced HPV-specific mucosal IgA. Alternative delivery systems and adjuvants will be required to enhance and evaluate immune responses following sublingual immunization in humans. TRIAL REGISTRATION:ClinicalTrials.govNCT00949572.

SUBMITTER: Huo Z 

PROVIDER: S-EPMC3306286 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.

Huo Zhiming Z   Bissett Sara L SL   Giemza Raphaela R   Beddows Simon S   Oeser Clarissa C   Lewis David J M DJ  

PloS one 20120316 3


<h4>Unlabelled</h4>The sublingual route has been proposed as a needle-free option to induce systemic and mucosal immune protection against viral infections. In a translational study of systemic and mucosal humoral immune responses to sublingual or systemically administered viral antigens, eighteen healthy female volunteers aged 19-31 years received three immunizations with a quadravalent Human Papilloma Virus vaccine at 0, 4 and 16 weeks as sublingual drops (SL, n = 12) or intramuscular injectio  ...[more]

Similar Datasets

| S-EPMC3572303 | biostudies-literature
| S-EPMC4481173 | biostudies-literature
| S-EPMC5905986 | biostudies-literature
| S-EPMC4243873 | biostudies-literature
| S-EPMC3943861 | biostudies-literature
| S-EPMC3988707 | biostudies-literature
| S-EPMC3906411 | biostudies-other
| S-EPMC6822509 | biostudies-literature
| S-EPMC4777253 | biostudies-literature
| S-EPMC4086631 | biostudies-literature